ISSN: 2165-7904

Journal de thérapie contre l'obésité et la perte de poids

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Centre international pour l'agriculture et les biosciences (CABI)
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catalogue en ligne SWB
  • Texte intégral du CABI
  • Taxi direct
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • Université de Bristol
  • publié
  • ICMJE
Partager cette page

Abstrait

Analysis for the Success Rate of Patients after Laparoscopic Sleeve Gastrectomy

Jose Baptista*, Vanessa Praxedes, Ana André, Edgar Rosa, Carlos Trindade and Luis Cortez

Background: Success rate of laparoscopic sleeve gastrectomy (SG) depends on disease and patient characteristics that are yet to be fully established.
Objectives: To evaluate which patient characteristics influence the success of SG.
Setting: National bariatric reference centre at a Public Hospital.
Methods: A retrospective study was performed based on prospectively collected data of patients who had bariatric surgery at our institution, during a 5 year period. Patients with 12 or more months of follow-up were included. We analyzed data from 133 SG. Seventy-nine percent of the patients were female with a median age of 46 years, a median baseline Body Mass Index (BMI) of 41 kg/m2 and a mean of 2.5 out of 7 comorbidities.
Results: After the first year, the mean percentage Excess Weight Loss (%EWL) was 69.3%, the mean change in BMI was -11.8 kg/m2 and the mean % total body weight loss was 27.4%. Surgical success (%EWL ≥ 50%) was achieved in 82% of the patients, with significant improvement or resolution of comorbidities (follow-up rate 76%-88%). We found statistical significant differences with baseline BMI (p<0.0001), with OSA (p<0.0001), with age (p=0.04) and with the number of comorbidities (p=0.05). Higher baseline characteristics implicated less %EWL. The presence of HTN or arthropathy and being a volume eater or a sweet eater did not influence surgical success (χ2 ≤ 0.01).
Conclusions: SG is an effective surgical treatment for obesity. After one year the majority of patients had surgical success and major comorbidities were mitigated or resolved. Success was influenced by specific patient and disease characteristics.